Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,046Revenue $M674Net Margin (%)15.9Altman Z-Score6.2
Enterprise Value $M2,906EPS $1.5Operating Margin %13.8Piotroski F-Score5
P/E(ttm)27.4Beneish M-Score-1.9Pre-tax Margin (%)19.4Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %--Quick Ratio2.2Cash flow > EarningsY
Price/Sales4.45-y EBITDA Growth Rate %16.4Current Ratio2.4Lower Leverage y-yN
Price/Free Cash Flow95.5y-y EBITDA Growth Rate %-3.1ROA % (ttm)10.5Higher Current Ratio y-yN
Dividend Yield %--PEG1.7ROE % (ttm)15.0Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M70.1ROIC % (ttm)15.7Gross Margin Increase y-yY

Gurus Latest Trades with WX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
WXRon Baron 2015-03-31 Add0.01%$32.73 - $41.7
($38.52)
$ 42.9812%Add 35.79%341,500
WXRon Baron 2014-12-31 Add0.01%$32.91 - $38.69
($35.32)
$ 42.9822%Add 24.81%251,500
WXRon Baron 2014-03-31 Add0.01%$32.58 - $39.86
($36.74)
$ 42.9817%Add 25.90%210,500
WXJulian Robertson 2013-12-31 Sold Out -2.4%$26.52 - $38
($31.52)
$ 42.9836%Sold Out0
WXRon Baron 2013-12-31 Add0.02%$26.52 - $38
($31.52)
$ 42.9836%Add 883.53%167,200
WXMario Gabelli 2013-12-31 Reduce$26.52 - $38
($31.52)
$ 42.9836%Reduce 24.71%65,200
WXJulian Robertson 2013-09-30 Reduce-0.85%$20.23 - $28.48
($23.68)
$ 42.9882%Reduce 35.37%576,218
WXRon Baron 2013-09-30 Add$20.23 - $28.48
($23.68)
$ 42.9882%Add 54.55%17,000
WXMario Gabelli 2013-09-30 Reduce$20.23 - $28.48
($23.68)
$ 42.9882%Reduce 26.05%86,600
WXJulian Robertson 2013-06-30 Reduce-0.34%$16.94 - $21.54
($19.52)
$ 42.98120%Reduce 13.99%891,618
WXRon Baron 2013-06-30 Buy $16.94 - $21.54
($19.52)
$ 42.98120%New holding11,000
WXJulian Robertson 2012-06-30 Add0.28%$13.37 - $14.84
($14.21)
$ 42.98202%Add 6.51%1,154,418
WXJulian Robertson 2012-03-31 Reduce-1.67%$11.43 - $15.39
($12.73)
$ 42.98238%Reduce 24.88%1,083,818
WXMario Gabelli 2011-12-31 Reduce-0.01%$10.78 - $13.92
($11.9)
$ 42.98261%Reduce 28.82%250,200
WXJulian Robertson 2011-09-30 Add1.9%$11.56 - $17.26
($14.19)
$ 42.98203%Add 38.60%1,442,806
WXGeorge Soros 2011-06-30 Sold Out $16 - $18.89
($17.29)
$ 42.98149%Sold Out0
WXJulian Robertson 2011-03-31 Add0.24%$15.07 - $18.49
($16.38)
$ 42.98162%Add 5.71%1,095,772
WXMario Gabelli 2011-03-31 Reduce-0.11%$15.07 - $18.49
($16.38)
$ 42.98162%Reduce 64.06%518,000
WXGeorge Soros 2011-03-31 Buy 0.05%$15.07 - $18.49
($16.38)
$ 42.98162%New holding250,000
WXJulian Robertson 2010-12-31 Add0.99%$16.05 - $17.72
($16.77)
$ 42.98156%Add 30.12%1,036,572
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

WX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


WX: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about WX :

    Quarterly/Annual Reports about WX:

      News about WX:

      Articles On GuruFocus.com
      Matthews Pacific Tiger Fund Adds 2 New Stocks to Portfolio May 05 2015 
      Baron Funds Comments on WuXi PharmaTech Feb 24 2014 
      Columbia Management's Top 5 New Buys Amid Buoyant Outlook Aug 12 2013 
      comment on WX Sep 15 2012 
      Stocks That Are Cheaper Than Julian Robertson Bought Jan 06 2012 
      Stocks That Julian Robertson Keeps Buying Dec 23 2011 
      Julian Robertson’s "smart idea, grounded on exhaustive research, followed by a big bet" Jun 24 2011 
      Julian Robertson’s Tiger Management Q1 Portfolio Update May 16 2011 
      Tiger Management Buys WX, CVC, THRX, Sells Apple Inc., Google Inc., Ebay Inc. Nov 15 2010 
      WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services Dec 09 2008 

      More From Other Websites
      5:45 am WuXi PharmaTech: Consortium including WuXi acquires Ambrx; terms not disclosed May 25 2015
      Fosun Pharma to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx May 22 2015
      Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S.... May 21 2015
      China Everbright Limited to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx May 21 2015
      Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S.... May 21 2015
      WuXi Launches e-Commerce Platform for Chemistry Products May 21 2015
      WuXi Launches e-Commerce Platform for Chemistry Products May 21 2015
      WuXi PharmaTech Announces First-Quarter 2015 Results May 13 2015
      WuXi PharmaTech Announces First-Quarter 2015 Results May 13 2015
      WuXi PharmaTech Announces Formation of a Special Committee to Evaluate Non-Binding Proposal May 13 2015
      WuXi PharmaTech Announces Formation of a Special Committee to Evaluate Non-Binding Proposal May 13 2015
      Q1 2015 Wuxi Pharmatech Cayman Inc Earnings Release - After Market Close May 13 2015
      Matthews Pacific Tiger Fund Adds 2 New Stocks to Portfolio May 05 2015
      Cablevision Systems Tops Q1 Earnings, Revenue Estimates - Analyst Blog May 04 2015
      WuXi PharmaTech (WX) Enters Overbought Territory - Tale of the Tape May 04 2015
      WuXi Biologics Begins Construction of the World's Largest Mammalian Cell Culture Manufacturing... Apr 30 2015
      WuXi Biologics Begins Construction of the World's Largest Mammalian Cell Culture Manufacturing... Apr 30 2015
      WuXi PharmaTech Announces Receipt of Proposal Apr 30 2015
      WuXi PharmaTech gets offer to be taken private by CEO-led consortium Apr 30 2015
      WuXi PharmaTech Announces Receipt of Proposal Apr 30 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK